StockNews.com began coverage on shares of Aeterna Zentaris (NASDAQ:AEZS – Free Report) (TSE:AEZ) in a report released on Saturday. The firm issued a sell rating on the biopharmaceutical company’s stock.
Aeterna Zentaris Stock Down 5.6 %
NASDAQ AEZS opened at $3.90 on Friday. The firm has a market cap of $7.00 million, a PE ratio of -0.26 and a beta of 1.55. The business’s fifty day simple moving average is $5.11 and its 200-day simple moving average is $6.64. Aeterna Zentaris has a 52 week low of $3.96 and a 52 week high of $12.00.
Aeterna Zentaris Company Profile
See Also
- Five stocks we like better than Aeterna Zentaris
- What does consumer price index measure?
- The Average 401k Balance by Age Explained
- Stock Trading Terms – Stock Terms Every Investor Needs to Know
- 3 Uranium Stocks To Gain as Microsoft Goes Nuclear to Power AI
- There Are Different Types of Stock To Invest In
- Biotech Boom Ahead? Key Stocks and ETFs to Watch Now
Receive News & Ratings for Aeterna Zentaris Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aeterna Zentaris and related companies with MarketBeat.com's FREE daily email newsletter.